Tag Archives: Syndrome

FDA Approves Livmarli (maralixibat) for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome

[unable to retrieve full-text content]FOSTER CITY, Calif.–(BUSINESS WIRE)–Sep. 29, 2021– Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leader in rare liver disease, today announced that the U.S. Food and Drug Administration (FDA) has approved Livmarli (maralixibat) oral solution for… Drugs.com – New Drug Approvals

Some Children With Covid-Related Syndrome Develop Neurological Symptoms

The Coronavirus Outbreak liveLatest Updates Maps and Cases Pause on Johnson & Johnson Vaccine Risk Near You Who Can Get Vaccinated? Advertisement Continue reading the main story Supported by Continue reading the main story Some Children With Covid-Related Syndrome Develop Neurological Symptoms New research found that half of young patients with the inflammatory condition, MIS-C,… Read More »

FDA Approves Nucala (mepolizumab) as the First and Only Biologic Treatment for Hypereosinophilic Syndrome (HES)

Print this page London UK 25 September 2020 — GlaxoSmithKline plc (GSK) today announced the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for the treatment of adult and pediatric patients aged 12 years and older with Hypereosinophilic Syndrome (HES) for ≥ six months without an identifiable non-hematologic secondary cause. The approval makes… Read More »

Medical News Today: Intermittent fasting can help ease metabolic syndrome

For those with metabolic syndrome, the necessary lifestyle and weight changes can be challenging. Now, a study has shown that eating within a certain time window can help tackle that. Share on PinterestNew research shows how intermittent fasting can help ease metabolic syndrome. Metabolic syndrome is an umbrella term for a number of risk factors… Read More »